Venture Life Group (LON:VLG) Shares Pass Above Fifty Day Moving Average – Here’s What Happened

Posted by Linda Flegge on Nov 20th, 2025

Venture Life Group plc (LON:VLG – Get Free Report) crossed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 55.62 and traded as high as GBX 59. Venture Life Group shares last traded at GBX 57.10, with a volume of 365,519 shares trading hands.

Venture Life Group Stock Up 0.3%

The business has a 50 day moving average price of GBX 55.62 and a 200 day moving average price of GBX 55.37. The firm has a market capitalization of £74.53 million, a P/E ratio of -76.58, a price-to-earnings-growth ratio of 5.67 and a beta of 0.30. The company has a debt-to-equity ratio of 28.45, a current ratio of 2.22 and a quick ratio of 1.48.

Venture Life Group (LON:VLG – Get Free Report) last released its quarterly earnings data on Tuesday, September 30th. The company reported GBX 0.83 earnings per share for the quarter. Venture Life Group had a return on equity of 0.99% and a net margin of 1.44%. On average, analysts predict that Venture Life Group plc will post 6.1391542 earnings per share for the current year.

Insider Buying and Selling

In other Venture Life Group news, insider Mark Adams acquired 88,999 shares of the stock in a transaction dated Friday, October 3rd. The shares were bought at an average cost of GBX 56 per share, for a total transaction of £49,839.44. Corporate insiders own 6.84% of the company’s stock.

About Venture Life Group

(Get Free Report)

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.

With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.